Only logged in customers who have purchased this product may leave a review.

ARA-290
- Research Grade
- 99% Purity
- Third-Party Verified
Availability: In stock
ARA-290
R569,00
ARA-290 (Cibinetide) is an erythropoietin-derived peptide investigated for its tissue-protective, anti-inflammatory and neuroprotective properties. It is intended for laboratory and scientific research purposes only.
Availability: In stock
Complimentary Purchase Kit
Every qualifying vial includes a complimentary purchase kit at no additional cost.
Research Overview
About ARA-290
ARA-290 is an 11-amino acid peptide derived from the helix-B domain of erythropoietin. It selectively activates the Innate Repair Receptor (IRR) without stimulating red blood cell production, making it a focus of research into neuropathy, tissue repair and inflammation.
How It Works in Research
Researchers study ARA-290 for its potential to support tissue repair and reduce inflammation while avoiding the erythropoietic effects associated with erythropoietin.
Research Applications
Peripheral neuropathy Small-fiber neuropathy Tissue repair Neuroprotection Inflammation research Pain modulation
Key Benefits
- Neuroprotection research
- Tissue protection studies
- Anti-inflammatory activity
- Nerve regeneration research
- Pain-modulation investigations
Product Specifications
- Product Name: ARA-290
- Alternate Chemical Name: Cibinetide (HBSP)
- Reference Strength: 10mg
- Purity Standard: ≥98% (HPLC)
- Appearance: White to off-white lyophilised powder
- Category: Tissue-Protective Peptide
Research Information
- CAS Number: 1208243-50-8
- Molecular Formula: C51H84N16O21
- Molecular Weight: 1257.3 g/mol
- Storage: 2–8°C after reconstitution
- Sequence: pGlu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-NH2
Mechanism of Action
ARA-290 binds the Innate Repair Receptor (EPOR/CD131 heterodimer), activating anti-inflammatory and anti-apoptotic signalling pathways that promote tissue repair without increasing red blood cell production.
Key Research Characteristics
Erythropoietin-derived peptide
Selective Innate Repair Receptor (IRR) agonist Non-erythropoietic Investigated in neuropathy and tissue repair research Designed for daily research protocols
Potential Benefits in Research
Neuroprotection research
- Tissue protection studies
- Anti-inflammatory activity
- Nerve regeneration research
- Pain-modulation investigations
Safety Profile
Clinical studies have generally reported good tolerability. Mild injection-site reactions may occur. Long-term safety continues to be evaluated.
Research Applications
REFERENCE RECONSTITUTION INFORMATION
ARA-290 is supplied as a lyophilised peptide and should be reconstituted using bacteriostatic water before laboratory research use.
Always follow sterile preparation techniques when handling research peptides.
General Preparation
- Draw 2.0 mL bacteriostatic water, inject slowly down the vial wall, gently swirl until fully dissolved, label with the preparation date and refrigerate at 2–8°C.
Reconstitution: Add 2.0 mL bacteriostatic water to a 10 mg vial. Final Concentration: 5 mg/mL
Reference Handling Information
Reference information for laboratory handling of ARA-290.
- Use a new sterile syringe for each preparation.
- Rotate injection sites during research protocols.
- Record preparation dates and usage.
- Discard the solution if it becomes cloudy or discoloured.
Reference Parameters (Week|Daily Dose|Units (U-100)|Volume)
| Week 1 | 2mg | 40 Units | 0.40ml |
|---|---|---|---|
| Weeks 2–5 | 4mg | 80 Units | 0.80ml |
Experimental Study Period
View Certificate of Analysis
View Certificate of Analysis Each batch of ARA-290 is independently tested by third-party laboratories. Download the Certificate of Analysis to verify purity, identity, and quality.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
FOR RESEARCH PURPOSES ONLY
This product is intended for research and laboratory use only. Always consult qualified researchers and follow appropriate safety protocols.






Reviews
There are no reviews yet.